Fukami, Kei

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

Ojima, A., Ishibashi, Y., Matsui, T., Maeda, S., Nishino, Y., Takeuchi, M., Fukami, K., & Yamagishi, S.-I. (2013) · The American Journal of Pathology

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 156

Oral L-Carnitine Supplementation Increases Trimethylamine-N-oxide but Reduces Markers of Vascular Injury in Hemodialysis Patients

Fukami, K., Yamagishi, S.-I., Sakai, K., Kaida, Y., Yokoro, M., Ueda, S., Wada, Y., Takeuchi, M., Shimizu, M., Yamazaki, H., et al. (2015) · Journal of Cardiovascular Pharmacology

Dialysis and Renal Disease ManagementMetabolism and Genetic Disorders

Cited by 84

Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 65

Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients

Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Ueda, Y., Suzuki, T., Yamada, S., Takeuchi, M., Fukami, K., Ueda, S., et al. (2009) · Metabolism

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 53

Receptor for advanced glycation endproducts and progressive kidney disease

Fukami, K., Taguchi, K., Yamagishi, S.-I., & Okuda, S. (2015) · Current Opinion in Nephrology and Hypertension

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 46